First Edition: September 2, 2010

Today's headlines include reports about a new study examining the impact of the health overhaul on the small business workforce.

KHN Column: Debunking Medicare MythsIn his latest Kaiser Health News column, James Capretta writes: "Here's a puzzle: Critics say Medicare Advantage plans -- the private insurance options offered to beneficiaries -- are inefficient and costly. But those same critics oppose vouchers for Medicare -- even though that would set up a direct competition between the private plans and the traditional fee-for-service program. What are they afraid of?" (Kaiser Health News).

More Workers At Small Businesses Will Get Medical Insurance Thanks to Healthcare Reform, Study PredictsIt's been nearly six months since the Patient Protection and Affordable Care Act of 2010 was signed into law, and it's still pretty unpopular. The Kaiser Health Tracking Poll for August found that 45% of Americans surveyed said they have a "somewhat unfavorable" or "very unfavorable" view of the law, compared with 43% who like it. A consensus of recent polls compiled by Pollster.com shows even more negativity  48% of Americans oppose the law, compared with only 42% who favor it (Los Angeles Times).

Hospital Profits Raise Eyebrows As Medical Costs Continue To SoarForbes magazine this week released its first-ever survey of America's most profitable hospitals, revealing that 24 hospitals with more than 200 beds make 25 cents or more for every dollar of patient revenue they take in. The report is being widely disseminated by the health insurance industry, which is pushing back against claims that health insurance profits - rather than rising medical costs - are to blame for rising premiums (The Hill's Healthwatch).

Desperate For A Treatment, One Physician Heals HimselfIn late May this year, Dr. Stephane Huberty inserted a needle into his upper arm and injected himself with a cloudy white vaccine previously tested only on rats and dogs. The reason for this desperate measure: Dr. Huberty suffers from myasthenia gravis, a rare neurological condition. It is one of more than 5,000 "orphan" diseases, so called because there are so few sufferers that most pharmaceutical companies are reluctant to invest in cures (The Wall Street Journal).

Stem-Cell Plaintiffs Cite Ethical MotivationThe two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research (The Wall Street Journal).